Clinical Trial Update: CRAIL - Controlled Reperfusion of the Acutely Ischemic Limb [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating controlled reperfusion for acutely ischemic limb (CRAiL) was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lower Extremity Ischemia

Snippet

Sponsor: University Hospital Freiburg | Conditions: Lower Extremity Ischemia | Phase 3 | Status: TERMINATED